Baxter International

Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Company Growth (employees)
Type
Public
HQ
Deerfield, US
Founded
1931
Size (employees)
48,000 (est)
Website
baxter.com
Baxter International was founded in 1931 and is headquartered in Deerfield, US

Key People/Management at Baxter International

José Almeida

José Almeida

Chairman, President and Chief Executive Officer
John Forsyth

John Forsyth

Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
Stephen Oesterle

Stephen Oesterle

Healthcare industry consultant, former Senior Vice President, Medicine & Technology, Medtronic
Peter Hellman

Peter Hellman

Former President, Chief Financial and Administrative Officer, Nordson Corporation
Munib Islam

Munib Islam

Partner and Head of Equities Research, Third Point LLC
Michael Mahoney

Michael Mahoney

Chairman, President and Chief Executive Officer, Boston Scientific Corporation
James Gavin

James Gavin

Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Carole Shapazian

Carole Shapazian

Former Executive Vice President, Maytag Corporation
Cathy Smith

Cathy Smith

Executive Vice President and Chief Financial Officer, Target Corporation
Thomas Stallkamp

Thomas Stallkamp

Lead Director and Founder and Principal, Collaborative Management LLC
K. Storm

K. Storm

Former Chairman of the Executive Board, AEGON N.V. (The Netherlands)
Albert Stroucken

Albert Stroucken

Former Executive Chairman and Chief Executive Officer, Owens-Illinois, Inc.
Thomas Chen

Thomas Chen

Former Senior Vice President and President, International Nutrition, Abbott Laboratories
Giuseppe Accogli

Giuseppe Accogli

Senior Vice President and President, Global Businesses
Laura Angelini

Laura Angelini

General Manager, Chronic Renal
Scott Bohaboy

Scott Bohaboy

Senior Vice President, Treasurer and Head of Global Planning
Wil Boren

Wil Boren

General Manager, Advanced Surgery
James Saccaro

James Saccaro

Executive Vice President and Chief Financial Officer

Baxter International Office Locations

Baxter International has offices in Deerfield, Ho Chi Minh City, Minneapolis, Newbury and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Show all (38)

Baxter International Financials and Metrics

Baxter International Financials

Baxter International's revenue was reported to be $10.2 b in FY, 2016
USD

Revenue (Q2, 2017)

2.6 b

Gross profit (Q2, 2017)

1.1 b

Gross profit margin (Q2, 2017), %

43%

Net income (Q2, 2017)

265 m

EBIT (Q2, 2017)

339 m

Market capitalization (23-Feb-2018)

37.9 b

Cash (30-Jun-2017)

3.8 b
Baxter International's current market capitalization is $37.9 b.
USDFY, 2015FY, 2016

Revenue

10 b10.2 b

Revenue growth, %

(40%)2%

Cost of goods sold

5.8 b6.1 b

Gross profit

4.1 b4.1 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

3.8 b4 b4.3 b4.2 b3.8 b3.9 b2.5 b2.4 b2.6 b2.6 b2.5 b2.6 b

Cost of goods sold

1.8 b2 b2.2 b2.1 b2 b2 b1.5 b1.4 b1.6 b1.5 b1.4 b1.5 b

Gross profit

1.9 b2 b2 b2.1 b1.8 b1.9 b1 b965 m972 m1.1 b1 b1.1 b

Gross profit Margin, %

52%50%48%49%48%49%42%41%38%42%42%43%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.7 b2.9 b2.2 b2.8 b

Inventories

3.5 b3.6 b1.6 b1.4 b

Current Assets

10 b10.4 b11.8 b6.6 b

PP&E

7.8 b8.7 b4.4 b4.3 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

2.4 b2 b1.9 b2.1 b2.5 b6.7 b2 b2.2 b2.6 b2.6 b2.9 b3.8 b

Inventories

3.6 b3.7 b3.8 b3.7 b3.5 b3.8 b1.7 b1.7 b1.6 b1.6 b1.5 b1.5 b

Current Assets

9.6 b9.4 b9.5 b9.6 b9.7 b14.5 b11.1 b8 b6.8 b6.6 b6.6 b7.7 b

PP&E

7.5 b8 b8.2 b8.4 b8.5 b9 b4.3 b4.4 b4.3 b4.3 b4.3 b4.3 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2 b2.5 b968 m5 b

Inventories

(311 m)(439 m)1.6 b80 m

Cash From Operating Activities

2.2 b3.2 b1.8 b1.7 b

Capital Expenditures

(1.5 b)(1.9 b)(911)(719 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

544 m556 m520 m468 m430 m762 m763 m3.4 b4.6 b4.7 b272 m537 m

Depreciation and Amortization

497 m593 m189 m395 m599 m194 m378 m

Inventories

(439 m)(205 m)(26 m)(25 m)(11 m)(29 m)(38 m)

Capital Expenditures

(1 b)(658 m)(184 m)(352 m)(519 m)(123 m)(279 m)
USDY, 2017

Revenue/Employee

54.3 k

Financial Leverage

1.9 x
Show all financial metrics

Baxter International Market Value History

Baxter International's Web-traffic and Trends

Baxter International Online and Social Media Presence

Baxter International Company Life and Culture

You may also be interested in